Scilex Holding Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
September 23, 2019 07:00 ET
|
Sorrento Therapeutics, Inc.
SAN DIEGO, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Scilex Holding Company (Scilex), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE), announced that it has confidentially...